Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 10

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 10
---
 to U.S. federal
and state income tax (including any applicable alternative minimum tax) on our taxable income at regular corporate tax rates, and we will
be ineligible to qualify as a REIT for four subsequent tax years. Even if we qualify as a REIT, we may be subject to certain state or
local income taxes, and our TRS will be subject to federal, state and local taxes on its income at regular corporate rates.

Our common stock is listed on the NYSE under the symbol “GMRE.” Our Series A Preferred Stock is listed on the NYSE under the symbol “GMRE PrA.” We intend to apply to list the Series B Preferred Stock on the NYSE under the symbol “GMRE PrB.” We are incorporated under the laws of Maryland. Our principal executive offices are located at 7373 Wisconsin Avenue, Suite 800, Bethesda MD, 20814. Our telephone number is (202) 524-6851. Our website is located athttp://www.globalmedicalreit.com. The
information found on, or otherwise accessible through, our website is not incorporated into, and does not form a part of, this prospectus
supplement or any other report or document we file with or furnish to the SEC.

<div align='center'>S-1</div>

THE OFFERING

| Issuer                                 | Global Medical REIT Inc.                                                                                                                |
| Series B Preferred Stock Offered by Us | 2,000,000 shares of 8.00% Series B Cumulative Redeemable Preferred                                                                      
 Stock, $0.001 par value per share (plus up to an additional 300,000 shares of Series B Preferred Stock if the underwriters exercise     
 their option to purchase additional shares in full). We reserve the right to reopen this series and issue additional shares of Series B 
 Preferred Stock at any time either through public or private sales.                                                                     |
| Ranking                                | The Series B Preferred Stock will rank, with respect to dividend rights and rights upon our liquidation, dissolution or winding         
 up:                                                                                                                                     |

| · | senior to our common stock and to any other class or series of our equity                                                                    
 shares with terms specifically providing that those equity shares rank junior to the Series B Preferred Stock with respect to rights         
 of dividend payments and the distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up of the Company; |

| · | on parity with our Series A Preferred Stock and any other series of                                                                     
 preferred or convertible preferred